This narrative review explores the role of probiotic-fortified functional foods as a strategic tool for disease prevention and health promotion. The scope includes a comparison against conventional dietary supplementation, focusing on a range of secondary outcomes such as host immunological and metabolic signalling pathways, intestinal barrier functioning, gut microbiota composition, production of short-chain fatty acids, expulsion of pathogens, regulation of immune cells, communication of the gut-brain axis, gastrointestinal health, systemic inflammation, metabolic maintenance, and neurobehavioral phenotypes.
The authors do not report specific primary outcomes, sample sizes, or follow-up durations. Consequently, no pooled effect sizes or specific numerical data regarding efficacy or safety are available within this source. The review does not report adverse events, serious adverse events, discontinuations, or tolerability data.
Limitations acknowledged by the authors or inherent to the narrative format include the absence of reported study populations and settings. The review characterizes these foods as a strategic tool but does not establish causal links due to the lack of randomized trial data or specific study-level details. Practice relevance is framed cautiously, noting the need for further evidence before broad clinical adoption.
View Original Abstract ↓
Foods fortified with probiotics are a fast-emerging field at the crossroads of food technology, nutritional biochemistry and microbiome science. The increased interest in the gut microbiota as a key controller of host metabolism, immunity and overall homeostasis has led to the creation of diets that provide key nutrients with live and beneficial microbes. Compared to the conventional dietary supplementation, there are improved microbe stability, bioavailability, and microbe-nutrient interactions of probiotic fortification of food matrices. This review is a summary of the literature on the impact of probiotics on the host immunological and metabolic signalling pathways, intestinal barrier functioning, and gut microbiota composition. The biological mechanisms of interaction of probiotics with the intestinal microenvironment are specifically focused on the production of short-chain fatty acids, expulsion of pathogens, the regulation of immune cells, and the communication of the gut-brain axis. New information that can be used to correlate the administration of probiotics with the improvement of gastrointestinal health, systemic inflammation, metabolic maintenance and neurobehavioral phenotypes is narratively synthesized based on available preclinical and clinical evidence. The opportunities of probiotic-enriched functional foods have been highlighted in this review as a strategic tool of disease prevention and health promotion in the context of the mechanistic knowledge in combination with translational health outcomes. The complexity in the interactions between microbial delivery systems and host physiology is the clue to the best efficacy, safety and the future innovation in the development of functional foods.